Gabapentin Tablets, Usp 600 mg (500 Tablets label)
Gabapentin Tablet
Product Images NDC 77771-178
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 77771-178). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Radha Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Gabapentin Tablets, Usp 600 mg (100 Tablets label)
Not available.*
Gabapentin Tablets, Usp 800 mg (500 Tablets label)
Gabapentin Tablets, Usp 800 mg (100 Tablets label)
Figure 1 (Image 01)
Figure 2 (Image 02)
This text appears to be describing a study or experiment involving the administration of different doses of a drug called Gabapentin over a period of weeks. The study compares the effects of a placebo (perhaps a control group) and two different doses of Gabapentin (1800 mg/day and 2400 mg/day) on pain scores. The pain scores are measured at baseline and at weeks 1 to 7, and the results are plotted on a graph.*
Figure 3 (Image 03)
Image-04 (Image 04)
This text appears to contain information related to calculating weight based on specific parameters. It mentions using the formula [l(l~ece(yw3)] x weight (kg), along with a notation that the value of x is 0.85 for female patients. Additionally, it states the value 72 x serum creatinine (mgfdL). This suggests that the text might be related to medical calculations or assessments, potentially in the context of patient care or research.*
Gabapentin Structural Formula (Image 05)
Image-09 (Image 09)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
